首页> 外文期刊>Bioorganic and medicinal chemistry >Design, synthesis, and biological evaluation of a highly water-soluble psoralen-based photosensitizer
【24h】

Design, synthesis, and biological evaluation of a highly water-soluble psoralen-based photosensitizer

机译:高度水溶性水溶性水溶性的光敏剂的设计,合成和生物学评价

获取原文
获取原文并翻译 | 示例
           

摘要

In recent years, photodynamic therapy (PDT) has been approved for treating various medical conditions, including cancer. PDT is a treatment that employs a particular drugs, called photosensitizers which work along with specific light source. The growth of this medical industry is expanding as it is another promising alternative to treat cancer which lessen the burden of treatments in patients. This includes the benefits of minimally invasive procedures and delivering high accuracy in targeting mutations. In recent two decades, cancer researchers have produced remarkable studies on developing photosensitizers that enhance understanding of biology and genetics of cancer. It is unfortunate that not all PDT can work as well as other profound treatment because PDT has various limitations like PDT leads photosensitivity reaction that arises when the photosensitizer remains in the body for a long period of time. In this paper, our studies centers on synthesizing a highly soluble photosensitizing agent with improved effectiveness on detecting cancer cells. (C) 2017 Elsevier Ltd. All rights reserved.
机译:近年来,光动力治疗(PDT)已被批准用于治疗各种医疗病症,包括癌症。 PDT是一种采用特定药物的治疗方法,称为光敏剂,与特定光源一起使用。这种医学行业的增长正在扩大,因为它是治疗癌症的另一种有希望的替代方案,这减轻了患者治疗的负担。这包括微创手术的益处并在靶向突变中提供高精度。近二十年来,癌症研究人员对发展的光敏剂造成了显着的研究,以加强对癌症生物学和遗传学的理解。不幸的是,并非所有的PDT都可以工作以及其他深刻的治疗,因为PDT具有PDT的各种限制,当光敏剂长时间留在体内时出现的PDT导致光敏反应。本文中,我们的研究中心在合成高度可溶性光敏剂,以改善癌细胞的有效性。 (c)2017 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号